CoChat

The Economic Burden of Elevated Blood Glucose Levels in 2012: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes Mellitus, and Prediabetes

Open access
Dall, Timothy M., Yang, Wenya, Halder, Pragna, Pang, Bo, Massoudi, Marjan, Wintfeld, Neil, Semilla, April P., Franz, Jerry, Hogan, Paul F. · 2014 · Diabetes Care

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To update estimates of the economic burden of undiagnosed diabetes, prediabetes, and gestational diabetes mellitus in 2012 in the U.S. and to present state-level estimates. Combined with published estimates for diagnosed diabetes, these statistics provide a detailed picture of the economic costs associated with elevated glucose levels. RESEARCH DESIGN AND METHODS: This study estimated health care use and medical expenditures in excess of expected levels occurring in the absence of diabetes or prediabetes. Data sources that were analyzed include Optum medical claims for ∼4.9 million commercially insured patients who were continuously enrolled from 2010 to 2012, Medicare Standard Analytical Files containing medical claims for ∼2.6 million Medicare patients in 2011, and the 2010 Nationwide Inpatient Sample containing ∼7.8 million hospital discharge records. The indirect economic burden includes reduced labor force participation, missed workdays, and reduced productivity. State-level estimates reflect geographic variation in prevalence, risk factors, and prices. RESULTS: The economic burden associated with diagnosed diabetes (all ages) and undiagnosed diabetes, gestational diabetes, and prediabetes (adults) exceeded $322 billion in 2012, consisting of $244 billion in excess medical costs and $78 billion in reduced productivity. Combined, this amounts to an economic burden exceeding $1,000 for each American in 2012. This national estimate is 48% higher than the $218 billion estimate for 2007. The burden per case averaged $10,970 for diagnosed diabetes, $5,800 for gestational diabetes, $4,030 for undiagnosed diabetes, and $510 for prediabetes. CONCLUSIONS: These statistics underscore the importance of finding ways to reduce the burden of prediabetes and diabetes through prevention and treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc14-1036

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 14

  1. American Diabetes Association 3. Comprehensive medical evaluation and assessment of comorbidities: Standards of Medical Care in Diabetes–2018. Diabetes Care 2018;41(Suppl. 1):S28–S37 [DOI] [PubMed] [Google Scholar]
  2. American Diabetes Association Economic costs of diabetes in the U.S. in 2017. Diabetes Care 2018;41:917–928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Centers for Disease Control and Prevention (CDC), 2010, National Health and Nutrition Examination Survey Data
  4. Turi KN, Buchner DM, Grigsby-Toussaint DS. Predicting risk of type 2 diabetes by using data on easy-to-measure risk factors. Prev Chronic Dis 2017;14:E23 [DOI] [PMC free article] [PubMed]
  5. Flegal KM, Panagiotou OA, Graubard BI. Estimating population attributable fractions to quantify the health burden of obesity. Ann Epidemiol 2015;25:201–207 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Breton M-C, Guénette L, Amiche MA, Kayibanda J-F, Grégoire J-P, Moisan J. Burden of diabetes on the ability to work: a systematic review. Diabetes Care 2013;36:740–749 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Asay GRB, Roy K, Lang JE, Payne RL, Howard DH. Absenteeism and employer costs associated with chronic diseases and health risk factors in the US workforce. Prev Chronic Dis 2016;13:E141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Loeppke R, Taitel M, Haufle V, Parry T, Kessler RC, Jinnett K. Health and productivity as a business strategy: a multiemployer study. J Occup Environ Med 2009;51:411–428 [DOI] [PubMed] [Google Scholar]
  9. Rodbard HW, Fox KM, Grandy S; Shield Study Group . Impact of obesity on work productivity and role disability in individuals with and at risk for diabetes mellitus. Am J Health Promot 2009;23:353–360 [DOI] [PubMed] [Google Scholar]
  10. Mitchell RJ, Bates P. Measuring health-related productivity loss. Popul Health Manag 2011;14:93–98 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Li Q, Blume SW, Huang JC, Hammer M, Graf TR. The economic burden of obesity by glycemic stage in the United States. Pharmacoeconomics 2015;33:735–748 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Leung MYM, Carlsson NP, Colditz GA, Chang S-H. The burden of obesity on diabetes in the United States: medical expenditure panel survey, 2008 to 2012. Value Health 2017;20:77–84 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Weaver CG, Ravani P, Oliver MJ, Austin PC, Quinn RR. Analyzing hospitalization data: potential limitations of Poisson regression. Nephrol Dial Transplant 2015;30:1244–1249 [DOI] [PubMed] [Google Scholar]
  14. Payne EH, Hardin JW, Egede LE, Ramakrishnan V, Selassie A, Gebregziabher M. Approaches for dealing with various sources of overdispersion in modeling count data: scale adjustment versus modeling. Stat Methods Med Res 2017;26:1802–1823 [DOI] [PubMed] [Google Scholar]

Cited by

See all 394

Metadata

Authors
Dall, T. M., Yang, W., Halder, P., Pang, B., Massoudi, M., Wintfeld, N., Semilla, A. P., Franz, J., & Hogan, P. F.
Affiliations
  • IHS Life Sciences, Washington, DC
  • Lewin Group (United States) (US)
  • Novo Nordisk Inc., Plainsboro, NJ
Corresponding author
Dall, Timothy M.
Venue
Diabetes Care
Published
2014-11-08
Volume
37
Issue
12
Pages
3172-3179
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2116695875
Cited by
382
References
23
Citations by year
2026: 15 · 2025: 13 · 2024: 26 · 2023: 36 · 2022: 32 · 2021: 52 · 2020: 41 · 2019: 36 · 2018: 29 · 2017: 32 · 2016: 38 · 2015: 29 · 2014: 3
FWCI
27.34
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
economic burden of diabetes, undiagnosed diabetes, prediabetes, gestational diabetes mellitus, hyperglycemia, health care costs, productivity loss, labor force participation
MeSH terms
Adult, Blood Glucose, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Prediabetic State, Pregnancy, United States, Prevalence, Diabetes, Gestational, Health Care Costs, Young Adult, Delayed Diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.